STAT+: Moderna and Merck say mRNA cancer vaccine succeeded in late-stage melanoma trial
STAT News · LC · trust 55/100
A personalized mRNA cancer vaccine succeeded in a late-stage melanoma study, results that could herald a new, powerful approach in oncology.
Read the original at STAT News →
Open in TruthVane →